Depreciation of Voyager Therapeutics, Inc. from 30 Sep 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Voyager Therapeutics, Inc. annual and quarterly Depreciation in USD history and change rate from 30 Sep 2014 to 31 Dec 2025.
  • Voyager Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $1,014,000, a 15% decline year-over-year.
  • Voyager Therapeutics, Inc. annual Depreciation for 2025 was $4,060,000, a 14% decline from 2024.
  • Voyager Therapeutics, Inc. annual Depreciation for 2024 was $4,731,000, a 6.5% increase from 2023.
  • Voyager Therapeutics, Inc. annual Depreciation for 2023 was $4,441,000, a 28% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Voyager Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $4,060,000 -$671,000 -14% 01 Jan 2025 31 Dec 2025 10-K 09 Mar 2026 2025 FY
2024 $4,731,000 +$290,000 +6.5% 01 Jan 2024 31 Dec 2024 10-K 09 Mar 2026 2025 FY
2023 $4,441,000 -$1,750,000 -28% 01 Jan 2023 31 Dec 2023 10-K 09 Mar 2026 2025 FY
2022 $6,191,000 +$1,026,000 +20% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025 2024 FY
2021 $5,165,000 +$1,348,000 +35% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $3,817,000 +$1,052,000 +38% 01 Jan 2020 31 Dec 2020 10-K 07 Mar 2023 2022 FY
2019 $2,765,000 +$648,000 +31% 01 Jan 2019 31 Dec 2019 10-K 08 Mar 2022 2021 FY
2018 $2,117,000 +$522,000 +33% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $1,595,000 +$983,000 +161% 01 Jan 2017 31 Dec 2017 10-K 03 Mar 2020 2019 FY
2016 $612,000 +$12,000 +2% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $600,000 +$416,000 +226% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018 2017 FY
2014 $184,000 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY

Voyager Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $1,014,000 -$182,000 -15% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $1,196,000 +$121,000 +11% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q1 2023 $1,075,000 -$1,737,000 -62% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q1 2022 $2,812,000 +$1,538,000 +121% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $1,274,000 +$432,000 +51% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $842,000 +$226,000 +37% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q1 2019 $616,000 +$160,000 +35% 01 Jan 2019 31 Mar 2019 10-Q 06 May 2020 2020 Q1
Q1 2018 $456,000 +$139,000 +44% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $317,000 +$181,000 +133% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $136,000 +$5,000 +3.8% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017 2017 Q1
Q3 2015 $63,000 -$97,000 -61% 01 Jul 2015 30 Sep 2015 10-Q 17 Dec 2015 2015 Q3
Q1 2015 $131,000 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q3 2014 $160,000 01 Jul 2014 30 Sep 2014 10-Q 17 Dec 2015 2015 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.